Versant Ventures is a leading healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great companies. The firm’s emphasis is on biotechnology companies that are discovering and developing novel therapeutics. With $2.4 billion under management and offices in the U.S., Canada and Europe, Versant has built a team with deep investment, operating and clinical expertise that enables a hands-on approach to company building. Since the firm’s founding in 1999, more than 70 Versant companies have achieved successful acquisitions or IPOs.

Venture Capital

Versant Ventures

Brad Bolzon

Rami Hannoush

Nigel Sheail

Lawrence Klein

Mehmet Badur

Rich Van Doren

Elizabeth Alcamo

Clare Ozawa

Guido Magni

Markus Enzelberger

Alex Mayweg

Max Eisenberg

Joel Drewry

Carlo Rizzuto

Tom Woiwode

Jerel Davis

Brian Busser

Angela McDonald

Tom Frohlich

Steve Edelson

Robin Praeger

Rachel Lane

Peter Emtage

Peppi Prasit

Markus Warmuth

Marcelo Bigal

The Senior Management team at Versant Ventures provides strategic oversight and decision-making for the firm’s investment activities. They leverage their extensive experience in investment, operations, and clinical expertise to identify promising biotechnology companies, develop investment strategies, and guide portfolio companies through growth stages, ultimately aiming for successful acquisitions or IPOs.

Senior Management

Leadership Team

Entrepreneurs and Advisors

Senior Management

About

Team members

Other teams at Versant Ventures

Leadership Team

Entrepreneurs and Advisors